Global Oncology/Anti-Cancer Drugs Sales Market Report 2017

October 2017 | 104 pages | ID: GFF44E7E52BWEN
QYResearch

Abstracts

In this report, the global Oncology/Anti-Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Oncology/Anti-Cancer Drugs for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Oncology/Anti-Cancer Drugs market competition by top manufacturers/players, with Oncology/Anti-Cancer Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amgen
• AstraZeneca
• Roche Diagnostics
• GlaxoSmithKline
• Merck
• Novartis
• AbbVie
• Sanofi
• EIMC United Pharmaceuticals
• Actavis

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oncology/Anti-Cancer Drugs for each application, including

• Blood Cancer (Leukaemia)
• Breast Cancer
• Gastrointestinal Cancer
• Respiratory/Lung Cancer
• Skin Cancer
• Other Cancers

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Oncology/Anti-Cancer Drugs Sales Market Report 2017

1 ONCOLOGY/ANTI-CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology/Anti-Cancer Drugs
1.2 Classification of Oncology/Anti-Cancer Drugs by Product Category
  1.2.1 Global Oncology/Anti-Cancer Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Oncology/Anti-Cancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Chemotherapy
  1.2.4 Targeted Therapy
  1.2.5 Immunotherapy (Biologic Therapy)
  1.2.6 Hormonal Therapy
  1.2.7 Others
1.3 Global Oncology/Anti-Cancer Drugs Market by Application/End Users
  1.3.1 Global Oncology/Anti-Cancer Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Blood Cancer (Leukaemia)
  1.3.3 Breast Cancer
  1.3.4 Gastrointestinal Cancer
  1.3.5 Respiratory/Lung Cancer
  1.3.6 Skin Cancer
  1.3.7 Other Cancers
1.4 Global Oncology/Anti-Cancer Drugs Market by Region
  1.4.1 Global Oncology/Anti-Cancer Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
  1.4.3 China Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
  1.4.7 India Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Oncology/Anti-Cancer Drugs (2012-2022)
  1.5.1 Global Oncology/Anti-Cancer Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Oncology/Anti-Cancer Drugs Market Competition by Players/Suppliers
  2.1.1 Global Oncology/Anti-Cancer Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Oncology/Anti-Cancer Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Oncology/Anti-Cancer Drugs (Volume and Value) by Type
  2.2.1 Global Oncology/Anti-Cancer Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Oncology/Anti-Cancer Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Oncology/Anti-Cancer Drugs (Volume and Value) by Region
  2.3.1 Global Oncology/Anti-Cancer Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Oncology/Anti-Cancer Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Oncology/Anti-Cancer Drugs (Volume) by Application

3 UNITED STATES ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  3.1.1 United States Oncology/Anti-Cancer Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
3.2 United States Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Players
3.3 United States Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
3.4 United States Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

4 CHINA ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  4.1.1 China Oncology/Anti-Cancer Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
4.2 China Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Players
4.3 China Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
4.4 China Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

5 EUROPE ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  5.1.1 Europe Oncology/Anti-Cancer Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
5.2 Europe Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Players
5.3 Europe Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
5.4 Europe Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

6 JAPAN ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  6.1.1 Japan Oncology/Anti-Cancer Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
6.2 Japan Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Players
6.3 Japan Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
6.4 Japan Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Oncology/Anti-Cancer Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

8 INDIA ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  8.1.1 India Oncology/Anti-Cancer Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
8.2 India Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Players
8.3 India Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
8.4 India Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

9 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Amgen
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Amgen Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 AstraZeneca
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 AstraZeneca Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Roche Diagnostics
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Roche Diagnostics Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Merck
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Merck Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Novartis
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Novartis Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 AbbVie
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 AbbVie Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Sanofi
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Sanofi Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 EIMC United Pharmaceuticals
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Actavis
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Actavis Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview

10 ONCOLOGY/ANTI-CANCER DRUGS MAUFACTURING COST ANALYSIS

10.1 Oncology/Anti-Cancer Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs
10.3 Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Oncology/Anti-Cancer Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS MARKET FORECAST (2017-2022)

14.1 Global Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Oncology/Anti-Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Oncology/Anti-Cancer Drugs Price and Trend Forecast (2017-2022)
14.2 Global Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Oncology/Anti-Cancer Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Oncology/Anti-Cancer Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Oncology/Anti-Cancer Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Oncology/Anti-Cancer Drugs Price Forecast by Type (2017-2022)
14.4 Global Oncology/Anti-Cancer Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oncology/Anti-Cancer Drugs
Figure Global Oncology/Anti-Cancer Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Immunotherapy (Biologic Therapy) Product Picture
Figure Hormonal Therapy Product Picture
Figure Others Product Picture
Figure Global Oncology/Anti-Cancer Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Oncology/Anti-Cancer Drugs by Application in 2016
Figure Blood Cancer (Leukaemia) Examples
Table Key Downstream Customer in Blood Cancer (Leukaemia)
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Gastrointestinal Cancer Examples
Table Key Downstream Customer in Gastrointestinal Cancer
Figure Respiratory/Lung Cancer Examples
Table Key Downstream Customer in Respiratory/Lung Cancer
Figure Skin Cancer Examples
Table Key Downstream Customer in Skin Cancer
Figure Other Cancers Examples
Table Key Downstream Customer in Other Cancers
Figure Global Oncology/Anti-Cancer Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Oncology/Anti-Cancer Drugs Sales Volume (K Units) (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Oncology/Anti-Cancer Drugs Sales Share by Players/Suppliers
Figure 2017 Oncology/Anti-Cancer Drugs Sales Share by Players/Suppliers
Figure Global Oncology/Anti-Cancer Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Oncology/Anti-Cancer Drugs Revenue Share by Players
Table 2017 Global Oncology/Anti-Cancer Drugs Revenue Share by Players
Table Global Oncology/Anti-Cancer Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Oncology/Anti-Cancer Drugs by Type (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology/Anti-Cancer Drugs by Type (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Oncology/Anti-Cancer Drugs by Region (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Sales Growth Rate by Region in 2016
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Oncology/Anti-Cancer Drugs by Region (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Revenue Growth Rate by Region in 2016
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Oncology/Anti-Cancer Drugs by Region (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Revenue Market Share by Region in 2016
Table Global Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Oncology/Anti-Cancer Drugs by Application (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Sales Market Share by Application (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players in 2016
Table United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure China Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players in 2016
Table China Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table China Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Europe Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players in 2016
Table Europe Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table Europe Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Japan Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players in 2016
Table Japan Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table Japan Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure India Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Players in 2016
Table India Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table India Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Table Amgen Basic Information List
Table Amgen Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure Amgen Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure AstraZeneca Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table Roche Diagnostics Basic Information List
Table Roche Diagnostics Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure Merck Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure Novartis Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure AbbVie Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure Sanofi Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table EIMC United Pharmaceuticals Basic Information List
Table EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table Actavis Basic Information List
Table Actavis Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Sales Global Market Share (2012-2017
Figure Actavis Oncology/Anti-Cancer Drugs Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology/Anti-Cancer Drugs
Figure Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs
Figure Oncology/Anti-Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology/Anti-Cancer Drugs Major Players in 2016
Table Major Buyers of Oncology/Anti-Cancer Drugs
Table Distributors/Traders List
Figure Global Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Oncology/Anti-Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources